Abstract:Abstract: Pharmaceutical design has made significant advancements in recent years, leading to the development of novel therapeutics with unprecedented efficacy and safety profiles. This review highlights the potential of these innovations to revolutionize healthcare and improve patient outcomes. The application of cutting-edge technologies like artificial intelligence, machine learning, and data mining in drug discovery and design has made it easier to find potential drug candidates. Combining big data and omics has led to the discovery of new therapeutic targets and personalized medicine strategies. Nanoparticles, liposomes, and microneedles are examples of advanced drug delivery systems that allow precise control over drug release, better bioavailability, and targeted delivery to specific tissues or cells. This improves the effectiveness of the treatment while reducing side effects. Stimuli-responsive materials and smart drug delivery systems enable drugs to be released on demand when specific internal or external signals are sent. Biologics and gene therapies are promising approaches in pharmaceutical design, offering high specificity and potency for treating various diseases like cancer, autoimmune disorders, and infectious diseases. Gene therapies hold tremendous potential for correcting genetic abnormalities, with recent breakthroughs demonstrating successful outcomes in inherited disorders and certain types of cancer. Advancements in nanotechnology and nanomedicine have paved the way for innovative diagnostic tools and therapeutics, such as nanoparticle-based imaging agents, targeted drug delivery systems, gene editing technologies, and regenerative medicine strategies. Finally, the review emphasizes the importance of regulatory considerations, ethical challenges, and future directions in pharmaceutical design. Regulatory agencies are adapting to the rapid advancements in the field, ensuring the safety and efficacy of novel therapeutics while fostering innovation. Ethical considerations regarding the use of emerging technologies, patient privacy, and access to advanced therapies also require careful attention.

Recent Advances and Computational Approaches in Peptide Drug Discovery

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

A Comprehensive Review on Current Advances in Peptide Drug Development and Design

Computational Peptidology: A New and Promising Approach to Therapeutic Peptide Design

Advancements in peptide-based therapeutics: Design, synthesis and clinical applications

Peptide Drugs: Current Status and it's Applications in the Treatment of Various Diseases

The latest trends in peptide drug discovery and future challenges

Recent Trends in Drug Design and Discovery

The Search for Peptide-Based Therapeutics Using Computational Tools

Engineering peptide drug therapeutics through chemical conjugation and implication in clinics

Peptide therapeutics: Targeting the undruggable space

Recent Advances in Pharmaceutical Design: Unleashing the Potential of Novel Therapeutics

Emerging trends in computational approaches for drug discovery in molecular biology

Rational, computer-enabled peptide drug design: principles, methods, applications and future directions

Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides

The role and future prospects of artificial intelligence algorithms in peptide drug development

The Medicinal Chemistry of Therapeutic Peptides: Recent Developments in Synthesis and Design Optimizations

Deep learning for advancing peptide drug development: Tools and methods in structure prediction and design

Bioinformatics Techniques For Drug Discovery: Applications For Complex Diseases

Recent Progress in Machine Learning-based Prediction of Peptide Activity for Drug Discovery.

Future Perspective: Harnessing the Power of Artificial Intelligence in the Generation of New Peptide Drugs